Enzon Pharmaceuticals (ENZN -11.5%) flips an early pre-market gain to trade lower after the...

|About: Enzon Pharmaceuticals, Inc. (ENZN)|By:, SA News Editor

Enzon Pharmaceuticals (ENZN -11.5%) flips an early pre-market gain to trade lower after the company unveiled a special dividend, a move that comes as the biopharmaceutical company concluded an earlier review of strategic alternatives and a workforce reduction. Late last year, Carl Icahn divulged a 13.3% stake in the company, and was taking an active interest in its operations and direction.